Physician profile
Brian Santini
NPI 1417995754
$421.24
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $49.35 · 2022: $19.65 · 2023: $17.74 · 2024: $17.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $93.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $60.67 | 2019 | |
| Gilead Sciences, INC. | $52.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $41.85 | 2019 | |
| Cranial Technologies, INC | $37.39 | 2022-2023 | Doc Band |
| Merck Sharp & Dohme LLC | $37.26 | 2020-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Amgen INC. | $29.34 | 2020 | |
| Lilly USA, LLC | $14.76 | 2019 | |
| Amarin Pharma, INC. | $14.74 | 2019 | |
| Vertiflex, INC. | $14.30 | 2019 | |
| Novo Nordisk INC | $12.93 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Santini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.